OXT and epilepsy: From a clinical perspective, our first tests in this preparation reveal a predictive value for treatments of ASD and epilepsy, showing a new potential for oxytocin as an anti-epileptic and suggest that extrasynaptic GABA signaling may be a potential target for the treatment of autism.